The product is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on...

The newly launched product is in the strengths of 0.8 g and 2.4 g packets, and is a therapeutic equivalent generic version of Renvela (seve...

The approved product is a generic equivalent to the reference listed drug (RLD), Renvela tablets, 800 mg of Genzyme Corporation, said Cipla.

Shares of the company opened at Rs 2,406 and touched a high and low of Rs 2,415 and Rs 2,355, respectively, in trade so far.

Nifty50 was firm at 9,871, up 82 points or 0.84 per cent around 12:50 pm (IST).

Here is a list of top stocks that are likely to be in focus in today's trading session.

Aurobindo Pharma has a total of 331 ANDA approvals (294 final nod, including 16 from Aurolife Pharma LLC and 37 tentative approvals) from t...

In the Nifty50 pack, 38 stocks were trading in green, while 13 stocks were in red.

Benchmark indices started the day on a firm note following firm global cues.

In the sectoral landscape, BSE Realty index gained the most at 2.16 per cent.

Sevelamer Carbonate oral suspension is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialy...